Cargando…
TNF-α and Tumor Lysate Promote the Maturation of Dendritic Cells for Immunotherapy for Advanced Malignant Bone and Soft Tissue Tumors
BACKGROUND: Dendritic cells (DCs) play a pivotal role in the immune system. There are many reports concerning DC-based immunotherapy. The differentiation and maturation of DCs is a critical part of DC-based immunotherapy. We investigated the differentiation and maturation of DCs in response to vario...
Autores principales: | Miwa, Shinji, Nishida, Hideji, Tanzawa, Yoshikazu, Takata, Munetomo, Takeuchi, Akihiko, Yamamoto, Norio, Shirai, Toshiharu, Hayashi, Katsuhiro, Kimura, Hiroaki, Igarashi, Kentaro, Mizukoshi, Eishiro, Nakamoto, Yasunari, Kaneko, Shuichi, Tsuchiya, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533902/ https://www.ncbi.nlm.nih.gov/pubmed/23300824 http://dx.doi.org/10.1371/journal.pone.0052926 |
Ejemplares similares
-
Correction: TNF-α and Tumor Lysate Promote the Maturation of Dendritic Cells for Immunotherapy for Advanced Malignant Bone and Soft Tissue Tumors
por: Miwa, Shinji, et al.
Publicado: (2013) -
Prognostic Value of Histological Response to Chemotherapy in Osteosarcoma Patients Receiving Tumor-Bearing Frozen Autograft
por: Miwa, Shinji, et al.
Publicado: (2013) -
Prognostic Value of Radiological Response to Chemotherapy in Patients with Osteosarcoma
por: Miwa, Shinji, et al.
Publicado: (2013) -
Successful correction of tibial bone deformity through multiple surgical procedures, liquid nitrogen-pretreated bone tumor autograft, three-dimensional external fixation, and internal fixation in a patient with primary osteosarcoma: a case report
por: Takeuchi, Akihiko, et al.
Publicado: (2015) -
Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study
por: Kimura, Hiroaki, et al.
Publicado: (2015)